111 related articles for article (PubMed ID: 12552813)
1. [Construction of mucosal vaccine derived from HBV surface antigen epitope A and the assay of its immunogenicity].
Liu X; Yang G; Qiu B; Tian P
Wei Sheng Wu Xue Bao; 2001 Oct; 41(5):625-9. PubMed ID: 12552813
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
3. [A fusion protein of rotavirus VP6 and cholera toxin B subunit: expression in Escherichia coli and analysis of biological activities].
Guo TX; Fang RX; Li GH; Qian Y
Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):621-5. PubMed ID: 11910752
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
[TBL] [Abstract][Full Text] [Related]
5. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
Shiau AL; Murray K
J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
[TBL] [Abstract][Full Text] [Related]
6. Oral immunogenicity of potato-derived HBsAg middle protein in BALB/c mice.
Youm JW; Won YS; Jeon JH; Ryu CJ; Choi YK; Kim HC; Kim BD; Joung H; Kim HS
Vaccine; 2007 Jan; 25(3):577-84. PubMed ID: 16945456
[TBL] [Abstract][Full Text] [Related]
7. M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes.
Shukla A; Katare OP; Singh B; Vyas SP
Int J Pharm; 2010 Jan; 385(1-2):47-52. PubMed ID: 19835938
[TBL] [Abstract][Full Text] [Related]
8. Gene fusion of cholera toxin B subunit and HBV PreS2 epitope and the antigenicity of fusion protein.
Shi CH; Cao C; Xhig JS; Li J; Ma QJ
Vaccine; 1995 Jul; 13(10):933-7. PubMed ID: 7483767
[TBL] [Abstract][Full Text] [Related]
9. [Expression and immunogenicity analysis of a recombinant fusion protein of V. Cholera ctB and H. pylori ure I].
Wang BN; Yang XF; Shi QF; Li MY; Chen CP; Cao K; Li H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 May; 22(3):276-9. PubMed ID: 16643777
[TBL] [Abstract][Full Text] [Related]
10. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
Li X; Yang X; Li L; Liu H; Liu J
Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
[TBL] [Abstract][Full Text] [Related]
11. [Immune response in mice induced by the fusion protein of HBcAg and HBV PreS1].
Chen XC; Zhou BP; Li MZ; Wang ZX; Wang HS; Zhang B; Tang W
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):184-5. PubMed ID: 12681075
[No Abstract] [Full Text] [Related]
12. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.
Singh SR; Hulett K; Pillai SR; Dennis VA; Oh MK; Scissum-Gunn K
Vaccine; 2006 Feb; 24(8):1213-24. PubMed ID: 16194585
[TBL] [Abstract][Full Text] [Related]
13. Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems.
Harakuni T; Sugawa H; Komesu A; Tadano M; Arakawa T
Infect Immun; 2005 Sep; 73(9):5654-65. PubMed ID: 16113283
[TBL] [Abstract][Full Text] [Related]
14. [Construction of recombinant adeno-associated virus carrying hepatitis B surface antigen gene and preliminary study of the gene expression and function].
Hu GF; Wu XB; Yu SY; Dong XY; Chen Q; Hou YD
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jun; 23(6):553-6. PubMed ID: 12810373
[TBL] [Abstract][Full Text] [Related]
15. Production of a recombinant cholera toxin B subunit-insulin B chain peptide hybrid protein by Brevibacillus choshinensis expression system as a nasal vaccine against autoimmune diabetes.
Yuki Y; Hara-Yakoyama C; Guadiz AA; Udaka S; Kiyono H; Chatterjee S
Biotechnol Bioeng; 2005 Dec; 92(7):803-9. PubMed ID: 16142801
[TBL] [Abstract][Full Text] [Related]
16. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of murine monoclonal antibodies targeting different epitopes of the hepatitis B virus surface antigen by using immunological as well as molecular biology and biochemical approaches.
Alves Vianna CO; da Silva E Mouta Júnior S; da Glória Teixeira Martins M; Batoreu NM; Queiroz JL; Gomes SA; Magalhães de Andrade Góes AC; Garcia Armoa GR; Marques CH; Baroni de Moraes MT
J Immunol Methods; 2006 Jun; 313(1-2):38-47. PubMed ID: 16753174
[TBL] [Abstract][Full Text] [Related]
18. [Prokaryocytic expression of the shortened hepatitis B surface antigen and antigenic analysis].
Ling N; Ren H; Peng ML; Xu HM; Qing YL
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):209-11. PubMed ID: 12716516
[TBL] [Abstract][Full Text] [Related]
19. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
[TBL] [Abstract][Full Text] [Related]
20. [Clone and express ctb-stx2b fusion gene in Enterohemrrhagic escherichia coli O157:H7 Shigeal toxin 2B subunit and V cholera toxin B subunit and the detection of their immunogenicity].
Li ZJ; Sun QZ; Jing HQ; Xu JG
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Apr; 29(4):378-82. PubMed ID: 18843998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
